Gesynta Pharma

0 followers


Developing unique drug candidates aiming to reduce harmful inflammation and increase blood flow in the body’s microvasculature.

Industries

Headquarters

Employees

Links

Org chart

Patric Stenberg

Collapse
Michaela Gertz
Chief Financial Officer
Göran Tornling
Chief Medical Officer
Charlotte Edenius
VP, Clinical R&D
Gunilla Ekström
VP, Project Management
Eva Björkstrand
Manager Pharmacology
Sven Sievers
Commercial Manager